EQT Reaches €9.6 Billion Deal for Molecular Testing Firm Qiagen

Fecha de publicación: 21 de octubre de 2026, 19:38

EQT AB has agreed to acquire Qiagen NV for around €9.6 billion ($10.8 billion), bringing an end to years of takeover speculation involving the European molecular testing company.